- Date 2 Aug 2021
Biofidelity Ltd, the cancer diagnostics company, today announces the opening of its US headquarters in Research Triangle Park, North Carolina, expanding its presence in the key US market ahead of its first product launch later this year. The location will house a state-of-the-art clinical cancer diagnostic laboratory that will perform the new ASPYRE-Lung assay for oncologists, pathologists, laboratories and pharmaceutical companies using Biofidelity’s break-through ASPYRE technology.
You might also be interested in these articles
Cambridge Science Centre Welcomes Rebecca Porter as New CEO
Wed 11 Dec 2024
Technology
Answer the call for speakers & start-ups for CW's International Conference
None
Thu 7 Nov 2024
CW (Cambridge Wireless Ltd)
Technology
Celebrating the Cambridge Tech Week Innovation Alley Award Winners
None
Wed 2 Oct 2024
CW (Cambridge Wireless Ltd)